Tarsus Pharmaceuticals (TARS) Other Non-Current Liabilities (2019 - 2026)
Tarsus Pharmaceuticals (TARS) posted Other Liabilities of $149.08 million for Q3 2026, compared with $10.15 million a year earlier and up 837.9% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Tarsus Pharmaceuticals' Other Liabilities came in at $10.6 million.
- Annual Other Liabilities shows a five-year compound annual growth rate of 77.3% (FY2020 to FY2025).
- In prior years, Tarsus Pharmaceuticals' Other Liabilities was $1.75 million in FY2023, $100,000 in FY2022 (-85.7%) and $699,000 in FY2021 (+15.5%).
- The Q3 2026 figure stands as the highest quarterly Other Liabilities in data going back to Q4 2019.
- The strongest year-over-year quarter for Other Liabilities in the past five years was Q3 2023, with growth of 718.7%; the weakest was Q1 2023, with a decline of 91.9%.
- According to Business Quant data, Other Liabilities for the three prior quarters was $15.9 million (Q2 2026), $16.08 million (Q1 2026) and $10.6 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Tarsus Pharmaceuticals | 3.35 Bn | 2.41 Bn | 180.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 149.08 Mn |
| Jun 30, 2026 | 15.90 Mn |
| Mar 31, 2026 | 16.08 Mn |
| Dec 31, 2025 | 10.60 Mn |
| Sep 30, 2025 | 10.15 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | 40,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 209,000.00 |
| Jun 30, 2022 | 343,000.00 |
| Mar 31, 2022 | 496,000.00 |
| Dec 31, 2021 | 699,000.00 |
| Sep 30, 2021 | 905,000.00 |
| Jun 30, 2021 | 524,000.00 |
| Mar 31, 2021 | 604,000.00 |
API Access
Tarsus Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();